Exploring the NK cell platform for cancer immunotherapy

JA Myers, JS Miller - Nature reviews Clinical oncology, 2021 - nature.com
Natural killer (NK) cells are cytotoxic lymphocytes of the innate immune system that are
capable of killing virally infected and/or cancerous cells. Nearly 20 years ago, NK cell …

Adoptive cellular therapies: the current landscape

MW Rohaan, S Wilgenhof, JBAG Haanen - Virchows Archiv, 2019 - Springer
For many cancer types, the immune system plays an essential role in their development and
growth. Based on these rather novel insights, immunotherapeutic strategies have been …

M1 and M2 macrophages: oracles of health and disease

C Mills - Critical Reviews™ in Immunology, 2012 - dl.begellhouse.com
The purpose of immunology is simple. Cure or prevent disease. M1/M2 is useful because it
is simple. M1/M2 describes the two major and opposing activities of macrophages. M1 …

Anatomy of a discovery: m1 and m2 macrophages

CD Mills - Frontiers in immunology, 2015 - frontiersin.org
M1 and M2 macrophage-type responses kill or repair in vivo. The unique ability of
macrophages to make these polar opposite type of responses provides primary host …

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

MW Rohaan, JH van den Berg, P Kvistborg… - … for immunotherapy of …, 2018 - Springer
The treatment of metastatic melanoma patients with autologous tumor-infiltrating
lymphocytes (TIL) shows robust, reproducible, clinical responses in clinical trials executed in …

A breakthrough: macrophage-directed cancer immunotherapy

CD Mills, LL Lenz, RA Harris - Cancer research, 2016 - AACR
Successful immunotherapy of cancer is becoming a reality aided by the realization that
macrophages play an important role in the growth or regression of tumors. Specifically …

Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?

P Muranski, A Boni, C Wrzesinski, DE Citrin… - Nature clinical practice …, 2006 - nature.com
In a recent clinical trial involving patients with metastatic melanoma, immunosuppressive
conditioning with fludarabine and cyclophosphamide resulted in a 50% response rate in …

Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells

PD Greenberg - Advances in immunology, 1991 - Elsevier
Publisher Summary This chapter attempts to identify the principles and issues elucidated in
animal models that may provide insights for the development of effective approaches to …

Tumor-Infiltrating Foxp3CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma

SA Siddiqui, X Frigola, S Bonne-Annee… - Clinical cancer …, 2007 - AACR
Abstract Purpose: Regulatory T cells (Tregs) have been implicated as inhibitors of
antitumoral immunity, and evidence suggests that elimination of Tregs may augment natural …

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+, 2-T cells. Tumor eradication does not require participation of cytotoxic T cells.

PD Greenberg, DE Kern, MA Cheever - The Journal of experimental …, 1985 - rupress.org
The ability of noncytolytic Lyt-1+, 2-T cells immune to FBL-3 leukemia to effect eradication of
disseminated FBL-3 was studied. Adult thymectomized, irradiated, and T-depleted bone …